Prybylski Dimitri, Manopaiboon Chomnad, Visavakum Prin, Yongvanitjit Kovit, Aramrattana Apinun, Manomaipiboon Parnrudee, Tanpradech Suvimon, Suksripanich Orapin, Pattanasin Sarika, Wolfe Mitchell, Whitehead Sara J
Thailand MOPH - U.S. CDC Collaboration, Nonthaburi 11000, Thailand; Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, 30333, USA.
Thailand MOPH - U.S. CDC Collaboration, Nonthaburi 11000, Thailand.
Drug Alcohol Depend. 2015 Mar 1;148:126-35. doi: 10.1016/j.drugalcdep.2014.12.034. Epub 2015 Jan 12.
Thailand's long-standing HIV sero-sentinel surveillance system for people who inject drugs (PWID) is confined to those in methadone-based drug treatment clinics and representative data are scarce, especially outside of Bangkok.
We conducted probability-based respondent-driven sampling (RDS) surveys in Bangkok (n=738) and Chiang Mai (n=309) to increase understanding of local HIV epidemics and to better inform the planning of evidence-based interventions.
PWID had different epidemiological profiles in these two cities. Overall HIV prevalence was higher in Bangkok (23.6% vs. 10.9%, p<0.001) but PWID in Bangkok are older and appear to have long-standing HIV infections. In Chiang Mai, HIV infections appear to be more recently acquired and PWID were younger and had higher levels of recent injecting and sexual risk behaviors with lower levels of intervention exposure. Methamphetamine was the predominant drug injected in both sites and polydrug use was common although levels and patterns of the specific drugs injected varied significantly between the sites. In multivariate analysis, recent midazolam injection was significantly associated with HIV infection in Chiang Mai (adjusted odds ratio=8.1; 95% confidence interval: 1.2-54.5) whereas in Bangkok HIV status was not associated with recent risk behaviors as infections had likely been acquired in the past.
PWID epidemics in Thailand are heterogeneous and driven by local factors. There is a need to customize intervention strategies for PWID in different settings and to integrate population-based survey methods such as RDS into routine surveillance to monitor the national response.
泰国针对注射吸毒者的长期艾滋病毒血清哨点监测系统仅限于接受美沙酮药物治疗诊所的人员,且缺乏代表性数据,尤其是在曼谷以外地区。
我们在曼谷(n = 738)和清迈(n = 309)进行了基于概率的应答者驱动抽样(RDS)调查,以增进对当地艾滋病毒流行情况的了解,并为循证干预措施的规划提供更充分的信息。
这两个城市的注射吸毒者流行病学特征不同。曼谷的总体艾滋病毒流行率更高(23.6% 对 10.9%,p < 0.001),但曼谷的注射吸毒者年龄较大,似乎感染艾滋病毒的时间较长。在清迈,艾滋病毒感染似乎是最近获得的,注射吸毒者更年轻,近期注射和性风险行为水平较高,而干预暴露水平较低。甲基苯丙胺是两个地点注射的主要毒品,多药使用很常见,尽管注射的具体毒品水平和模式在两个地点之间有显著差异。在多变量分析中,清迈近期使用咪达唑仑注射与艾滋病毒感染显著相关(调整后的优势比 = 8.1;95% 置信区间:1.2 - 54.5),而在曼谷,艾滋病毒感染状况与近期风险行为无关,因为感染可能是过去获得的。
泰国注射吸毒者中的艾滋病毒流行情况具有异质性,受当地因素驱动。有必要针对不同环境中的注射吸毒者定制干预策略,并将基于人群的调查方法(如RDS)纳入常规监测,以监测国家应对措施。